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ABSTRACT
Objective To evaluate COVID-19 infection and mortality
disparities in ethnic and racial subgroups in a state-wise
manner across the USA.
Methods Publicly available data from The COVID
Tracking Project at The Atlantic were accessed between
9 September 2020 and 14 September 2020. For each
state and the District of Columbia, % infection, % death,
and % population proportion for subgroups of race
(African American/black (AA/black), Asian, American
Indian or Alaska Native (AI/AN), and white) and ethnicity
(Hispanic/Latino, non-Hispanic) were recorded. Crude
and normalised disparity estimates were generated for
COVID-19 infection (CDI and NDI) and mortality (CDM
and NDM), computed as absolute and relative difference
between % infection or % mortality and % population
proportion per state. Choropleth map display was created
as thematic representation proportionate to CDI, NDI, CDM
and NDM.
Results The Hispanic population had a median of 158%
higher COVID-19 infection relative to their % population
proportion (median 158%, IQR 100%–200%). This was
followed by AA, with 50% higher COVID-19 infection
relative to their % population proportion (median 50%,
IQR 25%–100%). The AA population had the most
disproportionate mortality, with a median of 46% higher
mortality than the % population proportion (median 46%,
IQR 18%–66%). Disproportionate impact of COVID-19
was also seen in AI/AN and Asian populations, with
100% excess infections than the % population proportion
seen in nine states for AI/AN and seven states for Asian
populations. There was no disproportionate impact in the
white population in any state.
Conclusions There are racial/ethnic disparities in
COVID-19 infection/mortality, with distinct state-
wise patterns across the USA based on racial/ethnic
composition. There were missing and inconsistently
reported racial/ethnic data in many states. This
underscores the need for standardised reporting, attention
to specific regional patterns, adequate resource allocation
and addressing the underlying social determinants of
health adversely affecting chronically marginalised groups.

Strengths and limitations of this study
►► This study provides estimates of racial and ethnic

disparities in COVID-19 infection and mortality in a
state-wise manner across the USA.
►► Crude and normalised disparity estimates were
generated for COVID-19 infection and mortality,
computed as absolute and normalised difference
between % infection or % mortality and % population proportion for each racial and ethnic group by
state.
►► Choropleth map display was created as thematic
representation proportionate to the magnitude of
disparity estimate for each state, providing a comprehensive overview of disparities across the nation.
►► We used publicly available data from The COVID
Tracking Project, derived from state reporting
agencies, with inherent limitations related to inconsistent and incomplete reporting, particularly affecting the Asian and American Indian/Alaska Native
populations.
►► These data lack clinical and sociodemographic information to precisely understand the impact of
social determinants of health, age and other risk
factors on these disparities.

INTRODUCTION
Since January 2020, when the first COVID19-positive patient was identified in the USA,
there have been over 29 million reported
cases and over 500 000 reported fatalities as
of date.1 Although COVID-19 can affect all
ages regardless of medical comorbidities,
hospitalised patients are more likely to be
older and demonstrate at least one medical
comorbidity.2 It has also become increasingly evident that, in addition to traditional
risk factors, there are widespread racial and
ethnic disparities in COVID-19 infection and
mortality rates, with disproportionately higher
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MATERIALS AND METHODS
Study design, setting and data source
This is an observational study based on state-reported,
based data on COVID-19 infection and
population-
mortality compiled by ‘The COVID Tracking Project’.
The data source used is publicly available through ‘The
COVID Tracking Project’ between 10 September 2020
and 14 September 2020 (https://
covidtracking.
com/
race/dashboard). The COVID Tracking Project at The
Atlantic’s data and website content are published under a
Creative Commons CC BY 4.0 licence (CC BY 4.0).
2

Participants
The study population comprises individuals who are
positive for COVID-19 infection or were reported to
have COVID-19-related mortality based on state-reported
data as compiled by The COVID Tracking Project. Data
regarding racial and ethnic composition of populations
in US states and the District of Columbia in percentage
were from the US Census Bureau’s 2018 5-year estimates,
compiled by The COVID Tracking Project. Data around
the 9 September 2020 and 14 September 2020 reporting
timelines were used for this study. For each state and the
District of Columbia, % infection, % death, and % population proportion for subgroups of race and ethnicity
were recorded (online supplemental table 1). The %
COVID-19 infection or mortality in each group is defined
as: [number of infection or deaths in each group/total
number of COVID-19 infections or deaths] × 100.
Race was categorised into African American/black
(AA/black), Asian, American Indian or Alaska Native
(AI/AN), and white. Ethnicity was characterised into
Hispanic/Latino and non-Hispanic.
Please note the following variations in racial and ethnic
categorisations:
►► Some states categorise ‘Hispanic or Latino’ ethnicity
of any race including black population of Hispanic
ethnicity. All other race categories were defined as
not Hispanic or Latino. These states are Arizona,
California, Colorado, Connecticut, Delaware, Florida,
Georgia, Illinois, Maryland, Massachusetts, Mississippi,
Nevada, New Hampshire, New Jersey, New Mexico,
New York, Rhode Island, South Dakota, Texas, Utah,
Washington and Wyoming.
►► Some states report ‘Asian’ as a pan-
racial category,
including Asian, Pacific Islander and Native Hawaiian:
Arizona, Connecticut, Delaware, Michigan, Oklahoma, Virginia and Wisconsin. Montana classifies the
AI/AN population as a pan-racial category including
AI, AN, Pacific Islander and Native Hawaiian. This
limits the accuracy of comparison with percentage
population; however, the estimated disparity index
was generated for these states, given the population
percentage of Native Hawaiian and Pacific Islanders is
<1% and not likely to significantly impact the metric.
Inclusion and exclusion criteria
States reporting race and ethnicity data for a minimum
of 50% or more of their COVID-19 cases and deaths were
included in the analyses. States that used non-mutually
exclusive race categories, used or did not specify the
usage of other for AI/AN and/or Asian population, or
had numbers that were <1% were excluded from the analyses, as applicable.
Fifty-one states and the District of Columbia provide
race/ethnicity data for cases and deaths. The following
exclusions were made, where applicable:
►► Utah and Wyoming report non-
mutually exclusive
categories for race and ethnicity and hence were
entirely excluded from the analyses.
Xian Z, et al. BMJ Open 2021;11:e048006. doi:10.1136/bmjopen-2020-048006
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impact among vulnerable racial and ethnic minority
populations.3–7 A recent study based on the US Department of Veterans Affairs data showed an excess burden
of SARS-CoV-2 infection in African American/black and
Hispanic populations that was not entirely explained by
underlying medical conditions, residence or site of care;
however, the study did not find disparities in excess 30-day
mortality across racial and ethnic subgroups.8 This observation however is not aligned with a prior report from
the Centers for Disease Control and Prevention, which
showed poor outcomes in the African American/black
population with 1.4 times increased risk of hospitalisation, twice the risk of intensive care unit (ICU) care or
ventilator support, and 1.36 times increased risk of death
compared with the white population.9 Gross et al3 found a
robust association between African American/black race,
Latinx ethnicity and estimated age-adjusted COVID-19
mortality. Overall mortality was highest in African American/black, with 1 in 1020 facing death attributed to
COVID-19, followed by Indigenous Americans, Pacific
Islanders and Latinos.3 In addition, a study based on
community-
level disparities in urban US counties in
large metropolitan areas showed excess infections and
mortality that are not explained by income, bolstering
the complex causal pathways that culminate into these
striking disparities.10
Given the racial and ethnic diversity of the US population, its variable composition and thus unique challenges
faced by racial/ethnic minorities in each state, it is imperative to examine the extent of disparities in COVID-19
infections and mortality by race and ethnicity on a
national scale in a state-wise manner. Due to low population proportion of certain racial/ethnic groups in specific
states, they are prone to be overlooked in aggregate estimates. Furthermore, racial/ethnic composition of hospitalised patients might differ considerably from that of the
general population. In this context, state-wise analyses
from national population-based samples are critical for
adequate resource allocation and targeted policy implementation for improving health outcomes. Consequently,
we evaluated the extent of racial and ethnic disparities in
COVID-19 infection and mortality as a function of racial/
ethnic composition of the general population across all
US states and the District of Columbia.
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Patient and public involvement
There was no direct patient or public involvement in the
design and conduct of this study.
Statistical analysis
State-wise crude and normalised disparity estimates were
generated for COVID-19 infection (CDI and NDI) and
mortality (CDM and NDM), computed as absolute and
normalised difference in percentage points between %
infection or mortality in each racial and ethnic subgroup
and % population proportion of the same racial/ethnic
subgroup. Normalised disparity estimate was generated
to account for differences in population size for racial/
ethnic subgroups. CDI, NDI, CDM and NDM were
reported as median and IQR. Choropleth map display
was created as thematic representation proportionate
to the magnitude of disparity estimate for each state,
providing a comprehensive overview of disparities across
the nation. Percentage estimates that make up <1% of

the state population or COVID-19 cases or mortality were
excluded from analyses.

RESULTS
Racial/ethnic disparities in COVID-19 infection
COVID-19 infection was disproportionately high in the
Hispanic, AA/black, AI/AN and Asian populations,
relative to their population proportion in many states
(figures 1 and 2).
Overall across the nation, the Hispanic population
experienced the highest CDI and NDI, followed by the
AA/black population. The Hispanic population had a
median CDI of 14% and an IQR of 8%–19%, and the AA/
black population had a median CDI of 5% and an IQR of
3%–9%. Similarly, both Hispanic and AA/black populations experienced higher NDI. The Hispanic population
had a median NDI of 158% and an IQR of 100%–200%,
in contrast to the AA/black population median NDI of
50% and IQR of 25%–100%.
The Hispanic population experienced ≥100% NDI in
35 out of 44 analysed states, while the AA/black population experienced ≥100% NDI in 14 states across the
nation. In contrast, the overall median CDI in the white
population was −18% and the IQR −23% to −13%, and
the median NDI was −26% and the IQR −39% to −17%,
respectively.
Disproportionate impact of COVID-19 was also seen
in the AI/AN and Asian populations in many states
(figures 1 and 2), with 100% or more NDI in nine states
for the AI/AN population and in seven states for the
Asian population.
Choropleth maps show the most striking disparity
in COVID-19 infections in the AA/black population in
the state of Maine, where 22% of the total COVID-19

Figure 1 Choropleth map showing crude disparity estimates for COVID-19 infections, computed as absolute percentage
point difference between % COVID-19 infection and % population proportion by ethnic/racial groups across US states and the
District of Columbia. AA, African American; AI, American Indian; AN, Alaska Native.
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Texas reported race and ethnicity data on less than
3% of its COVID-19 cases and hence was excluded
from analyses for COVID-19 cases.
►► Texas, West Virginia, Florida, Hawaii, Indiana, Maryland, New Jersey, Pennsylvania and New York either
include AI/AN and/or Asian race categories in ‘other’
or do not specify if these are included in ‘other’ and
hence were excluded from the specific analyses on
these racial groups.
►► Numbers that are too small for a reliable disparity
estimation (<1%), including percentage population, infection or mortality, were excluded from the
analyses.
Additional detailed data can be accessed at https://
covidtrackingcom/race/dashboard.
►►
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infections were seen in the AA/black population, who
otherwise only accounts for 1% of the total population
(figure 1).
Racial/ethnic disparities in COVID-19 mortality
Overall, across all states, the AA/black population had
the most disproportionately high COVID-19 mortality
(figures 3 and 4). The AA/black population had a
CDM median of 5% (IQR: 1%–11%) and an NDM
median of 46% (IQR: 18%–66%). Hispanic, white,
AI/AN and Asian populations showed 0 or <0 median
CDM and NDM. However, some states showed disparities in mortality even in these subgroups, such as the
Hispanic population with 17% CDM and 43% NDM

in Texas, while the AI/AN subgroups had 45% CDM
and 500% NDM in New Mexico. The Asian population
had 4% CDM and 50% NDM in Nevada. Choropleth
map reveals the most striking disparity in COVID-19
mortality was present in the AI/AN population in the
states of Montana and New Mexico (figures 3 and 4). In
Montana, 34% of the total COVID-19 deaths were seen
in the AI/AN population, who otherwise only accounts
for 6% of the total population. In New Mexico, 54%
of the total COVID-19 deaths were seen in the AI/AN
population, who otherwise only accounts for 9% of the
total population (figure 4).

Figure 3 Choropleth map showing crude disparity estimates for COVID-19 mortality, computed as absolute percentage point
difference between % COVID-19-related mortality and % population proportion by ethnic/racial groups across US states and
the District of Columbia. AA, African American; AI, American Indian; AN, Alaska Native.
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Figure 2 Choropleth map showing normalised disparity estimates for COVID-19 infections computed as CDI normalised by
% population proportion of each ethnic/racial group across US states and the District of Columbia. AA, African American; AI,
American Indian; AN, Alaska Native; CDI, crude disparity estimates for COVID-19 infection.
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DISCUSSION
We found widespread racial and ethnic disparities in
COVID-19 infection and mortality. We summarised these
findings in a state-wise manner across the USA. Our findings are consistent with previous similar reports.3–7 11
Hispanic and AA/black populations were the most
disproportionately impacted by COVID-19 infections.
The AA/black population was the most disproportionately affected by COVID-19-related mortality across the
nation. AI/AN and Asian populations also showed disproportionately higher infection and mortality in some states,
although this is susceptible to underestimation since
many states with less than 1% representation for these
subgroups were excluded from the analyses. In addition,
the mortality disparity estimates in our study were not
age-adjusted. This can underestimate the mortality for
populations that have greater proportion of younger individuals, as previously shown.3 We also found widespread
inconsistencies in reporting from state agencies, causing
missing or incomparable data particularly affecting the
Asian and AI/AN subgroups.
We do not have specific information on social determinants of health (SDOH) to understand the exact aetiologies of these disparities. However, based on a vast body of
prior evidence, SDOH has a significant impact in driving
these disparities, mediated via the environment, occupation and access to care, and higher burden of comorbidities in chronically marginalised populations.12–14
The higher burden of comorbidities is also known to
adversely impact disease severity in COVID-19.15 Comorbidities such as obesity, hypertension and diabetes may
result in a chronic, proinflammatory state that compounds
the cytokine release syndrome observed in COVID-19.16 17
These comorbidities have underlying SDOH predictors,
related to food insecurity, economic and environmental
Xian Z, et al. BMJ Open 2021;11:e048006. doi:10.1136/bmjopen-2020-048006

instability, and psychosocial stress, chronically accentuating the chronic allostatic load on racial/ethnic minority
populations.18 The impact of these factors can be further
exacerbated by lack of access to quality and timely care in
these minority population subgroups.6 19 20
Access to healthcare is another determinant of
these disparities. Often minority populations rely on
government-funded healthcare facilities for their medical
needs. Many of these have under-resourced infrastructure, not equipped to mobilise at an operational scale,
which is necessary for a rapidly spreading potentially
lethal infection like COVID-19. This is particularly relevant for the AI/AN population, who relies heavily on
the Indian Health Service (IHS) to provide medical care
in tribal reservations, including the Navajo Nation, the
largest reservation severely impacted by COVID-19. IHS
facilities are unable to respond to a crisis of this magnitude
due to limited hospital beds and ICUs. In addition, IHS
facility may be inaccessible to those in remote areas and
IHS does not cover care provided by non-IHS providers
or facilities, a critical factor that was not addressed in the
funds provided by the The Coronavirus Aid, Relief, and
Economic Security Act (CARES Act) stimulus bill.5
Communication challenges due to limited English
proficiency and lower health literacy result in additional barriers to seeking and adhering to treatment.21–23
Furthermore, these groups are more likely to be ‘front-
line workers’ (eg, grocery, public transport or healthcare
employees) without the flexibility of remote employment.24 25 It is important to note that socioeconomic
differences are not a singular explanation for disparities.
For example, a recent study found use of public transportation as an independent predictor of COVID-19
disparities even after adjusting for income, poverty rates,
education, occupation or access to insurance in AA/black
5
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Figure 4 Choropleth map showing normalised disparity estimates for COVID-19 mortality, computed as CDM normalised by
% population proportion of each ethnic/racial group across US states and the District of Columbia. AA, African American; AI,
American Indian; AN, Alaska Native; CDM, crude disparity estimate for COVID-19 mortality.
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